Announcements Trials
Browse Landscape

Phase

Phase 2 87Phase NA 17Phase 1 13Phase 3 12Phase 1/2 10Phase 2/3 5Phase EARLY_PHASE1 2Phase 4 1

Status

Recruiting 3Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 4Thoracic 1Other solid neoplasm 1

Conditions

Stomach Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Neoplasms 1Locally Advanced Rectal Adenocarcinoma 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 54Cyclophosphamide 42Fluorouracil 41Oxaliplatin 36Capecitabine 35Docetaxel 34Gemcitabine 32Drug Therapy 32Radiotherapy 31Paclitaxel 25Dexamethasone 23Carboplatin 23Leucovorin 21Etoposide 17Doxorubicin 17Cytarabine 17apatinib 16Methotrexate 16Magnetic Resonance Spectroscopy 14Radiation 13Epirubicin 13Busulfan 13Bevacizumab 13Surgical Procedures, Operative 12Neoadjuvant Therapy 12Letrozole 12Decitabine 12Saline Solution 11Irinotecan 11venetoclax 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2/3 × OTHER × Immunotherapy × Clear all
NCT07596290 2026-05-22

RADICAL

Beijing Friendship Hospital

Phase 2/3 Not yet recruiting
342 enrolled
Gastrointestinal

Locally Advanced Rectal Adenocarcinoma

NCT07000253 2026-05-07

OMEC-5

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 2/3 Recruiting
290 enrolled
Gastrointestinal

Esophageal Neoplasms, Neoplasms, Stomach Neoplasms

NCT07034326 2025-06-24

Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

Phase 2/3 Recruiting
405 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06907602 2025-04-02

ONTRESCC

Peking Union Medical College Hospital

Phase 2/3 Recruiting
120 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05955157 2024-01-10

Combined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma

University of Malaya

Phase 2/3 Unknown
52 enrolled
GastrointestinalOther solid neoplasm

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡